ITT Educational Services Inc. has been sued by investors who accuse the for-profit college of making misstatements about its private student-loan program, which was the subject of a subpoena from U.S. regulators.
Eli Lilly and Co. and five other big drugmakers avoided paying $7 billion in U.S. taxes last year by shifting their profits overseas. The strategy has drawn the ire of some legislators.
Washington, D.C.-based Carlyle Group LP, the world’s second-biggest private-equity firm, was awarded a contract to manage a new $150 million investment fund on behalf of the Indiana Public Retirement System.
Eli Lilly and Co. has sued Roche Holding AG’s Genentech unit, asking a court to invalidate patents used to make treatments for cancer and autoimmune diseases.
Shares of ITT Educational Services Inc., one of the country's largest for-profit colleges, tumbled nearly 17 percent Monday after it disclosed that U.S. regulators subpoenaed documents related to private loan programs for its students.
Researchers suspect the sex hormone known to increase libido and musculature could also play a role in preventing a form of diabetes that tends to strike later in life and afflicts more than 330 million people worldwide.
Indianapolis-based Dow Agrosciences LLC and two other pesticide makers won a bid to overturn U.S. National Marine Fisheries Service proposals to protect salmon when an appeals court found the agency’s decision “arbitrary and capricious.”
The governing body for college sports says that the state is violating the U.S. Constitution by passing a law that confiscates the $60 million sanction imposed against Penn State in the Jerry Sandusky child-abuse case.
One day after the NCAA fired its head of enforcement for allegedly botching an investigation into the University of Miami, the Indianapolis-based organization is accusing the school of failing to control its athletic department, ESPN reported.
Roche AG and Eli Lilly and Co., two drugmakers racing to develop treatments for some of the least understood brain disorders, may gain the most from a U.S. government boost in funding to fully map the human brain.
Former Amerigroup Corp. CEO James Carlson will leave WellPoint Inc., the company said Friday—three days after he was passed over for the Indianapolis-based insurer’s top job.
The Indianapolis-based National Collegiate Athletic Association asked a federal judge to throw out a Pennsylvania lawsuit challenging penalties imposed on Pennsylvania State University over the Jerry Sandusky child-abuse case.
Eli Lilly said it is halting testing of experimental drug tabalumab because the studies show the medicine is not effective. The company said it expects to take a $50 million charge in the first quarter related to the research expenses from the drug.
The Indianapolis-based shopping mall owner reported funds from operations, a key measure of a real estate company's performance, of $2.29 a share, topping the average estimate from analysts of $2.17 a share.
Thinking that brothers Jim and John Harbaugh might go head to head in this year’s Super Bowl, Roy Fox last year filed applications to register “Harbowl” and “Harbaugh Bowl” as U.S. trademarks.
Mall owners, including Simon Property Group Inc. and General Growth Properties Inc., have been moving on from struggling retail centers as the economic rebound drives them to focus on the best-performing markets.
The Labor Department said the rapid drop in claims may be a short-term distortion. Long-term and extended claims for unemployment increased.
WellPoint Inc. is still considering former Amerigroup Corp. CEO James Carlson among several finalists to become CEO. Statements and filings this month have fueled speculation among analysts and shareholders that Carlson has vaulted ahead of other prospects.
Ardagh Group said it has agreed to buy Indiana-based glass bottle and jar manufacturer Verallia North America, which has about 4,400 employees at 13 manufacturing plants in the United States, including more than 650 workers in Indiana.
Johnson & Johnson, the world’s largest seller of health-care products, won the backing of U.S. advisers for a diabetes pill the company is seeking to make the first in a new family of drugs for managing blood sugar.
